NCT03719027View on ClinicalTrials.gov

Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH)

NACompletedINTERVENTIONAL
Enrollment

2,003

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

June 29, 2022

Study Completion Date

June 29, 2022

Conditions
Chronic Thromboembolic Pulmonary Hypertension (CTEPH)Pulmonary Embolism
Interventions
DIAGNOSTIC_TEST

Study population

Dyspnea assessment (NYHA functional class) EKG Echocardiography

Trial Locations (4)

75015

Hôpital européen Georges-Pompidou, Paris

Unknown

CHU Jean Minjoz, Besançon

La Cavale Blanche, Brest

Hôpital Nord, Saint-Etienne

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03719027 - Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH) | Biotech Hunter | Biotech Hunter